Does PET imaging have a role in renal cancers after all?

Lancet Oncology

Volumn 8, Issue 4, 2007, Pages 279-281

  Powles, Thomas ^a   Ell, Peter J ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER 64; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GLUCOSE TRANSPORTER 1; IODINE 124; MONOCLONAL ANTIBODY G250 I 124; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER INVASION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; INCIDENTAL FINDING; INTERMETHOD COMPARISON; ISOTOPE LABELING; KIDNEY CANCER; LETTER; MOLECULAR IMAGING; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REPORTER GENE; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR VASCULARIZATION;

ANTIBODIES, MONOCLONAL; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IODINE RADIOISOTOPES; KIDNEY; KIDNEY NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 33947496265     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70080-3     Document Type: Letter

References (17)

1. 124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol. published online March 7, 2007; DOI:10.1016/S1470-2045(07)70044-X
2. Powles T., Murray I., Brock C., et al. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol. published online Jan 25, 2007; DOI:10.1016/j.eururo.2007.01.061
3. Aide N., Cappele O., Bottet P., et al. Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 30 (2003) 1236-1245
4. Kang D., White Jr. R., Zuger J., et al. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 171 (2004) 1806-1869
5. Bosniak M. How does one deal with a renal cyst that appears to be Bosniak class II on a CT scan but that has sonographic features suggestive of malignancy (e.g., nodularity of wall or a nodular, irregular septum)?. AJR Am J Roentgenol 163 (1994) 216
6. Aronson S., Frazier H., Baluch J., et al. Cystic renal masses: usefulness of the Bosniak classification. Urol Radiol 13 (1991) 83-90
7. Lang E., Macchia R., Gayle B., et al. CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 2F): accuracy and impact on clinical management. Eur Radiol 12 (2002) 2518-2524
8. Kutikov A., Fossett L., Ramchandani P., et al. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68 (2006) 737-740
9. McKiernan J., Yossepowitch O., Kattan M., et al. Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 60 (2002) 1003-1009
10. Remzi M., Ozsoy M., Klingler H., et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 176 (2006) 896-899
11. Rendon R., and Jewett M. Expectant management for the treatment of small renal masses. Urol Oncol 24 (2006) 62-67
12. Belldegrun A., Tsui K., deKernion J., and Smith R. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 17 (1999) 2868-2875
13. McKiernan J., Simmons R., Katz J., and Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59 (2002) 816-820
14. Kattan M., Reuter V., Motzer R., et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
15. Zambrano N., Lubensky I., Merino M., et al. Histopathology and molecular genetics of renal tumors toward unification of a classification system. J Urol 162 (1999) 1246-1258
16. Pignot G., Elie C., Conquy S., et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 69 (2007) 230-235
17. Beck S., Patel M., Snyder M., et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 11 (2004) 71-77